Aarti Drugs Ltd

NSE: AARTIDRUGS · BSE: 524348 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹418.50
Market cap: ₹3,820 Cr
Revenue (annual): ₹2,565 Cr
Net profit (annual): ₹194.9 Cr
P/E (TTM): 20.0×Sector 47.4×
Promoter holding: 54.43%-0.60% QoQ
FII holding: 1.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 3 Earnings Call 3 Other Announcement 2 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Financial Results 1 Employee Stock Options 1 Board Meeting Outcome 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

18 Jul 2026 22:40 IST NSE

Adverse Business Impact

Aarti Drugs Adverse Business Impact

Aarti Drugs received a closure directive from GPCB for its Saykha manufacturing unit due to alleged non-compliances. The company is taking corrective measures for revocation.

Read the filing ↗